overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Surgical Intervention

InterStim Therapy
  • Used in patients with urinary urgency, frequency, urge incontinence and retention
  • A small device implanted under the skin of one of the upper buttocks
  • Works by gently stimulating the sacral nerves to help the bladder function normally
Augmentation Cystoplasty
  • Small piece of tissue from the intestine is added to the wall of the bladder to increase the size of the bladder
  • Done by opening the abdomen and sometimes through the use of laparoscope
  • Consider in patients with non-progressive neurological disorders and impaired bladder storage
Urinary Diversion
  • Procedure is only done if all other options have failed to treat overactive bladder (OAB) symptoms
  • Tubes from the kidneys to the bladder and ureters are routed directly to the outside of your body
Nerve Stimulation
Sacral nerve stimulation
  • Small pulse generator is implanted under the skin of the buttock to send electrical signals to the nerves that control the bladder
Peroneal nerve stimulation
  • Another pulse generator used to stimulate the nerves controlling the bladder
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
In addition to the known evils of maternal smoking during pregnancy on the son’s semen quality, prenatal exposure to paternal smoking can also be harmful, according to data from a large Danish National Birth Cohort (DNBC) presented at the ESHRE 2019 Meeting.
Roshini Claire Anthony, 13 Jun 2019

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

26 Mar 2017
Siblings of men with oligozoospermia are susceptible to any-site cancer and acute lymphoblastic leukaemia, according to a recent study.
06 Jul 2019
Intraureteral seems better than conventional stent placement as it results in less stent-related discomfort, according to a study. This novel placement method is safe and feasible and may be used immediately in daily clinical practice.